New Users  |  Log In Contact Us


Home

SIG Leadership
SIG Newletter
Minutes
News
Discussion
Membership Directory
Join SIG
Find Other SIGs


You are here: HomeDiscussion

Discussion



To participate in the discussion forum, log into the Virtual Community using your ONS Username and Password and then subscribe to the discussion.

Forgot your username or password? Click here.

Don't have an ONS Profile? Create one now.

Please contact membership@ons.org if you notice any postings on this site that relate to SPAM.



Targeted and Biological Therapies SIG Discussion

 
Subscribe to discussion

Discussions Last Post Posted By Total Posts
Bevacizumab and port placement 7/15/09 kdabueg none
Any suggestions for the newsletter? 5/5/09 kdabueg none
EGFR-TKI patient education 7/25/08 guest 1
safety precautions 6/18/08 guest none
multi-modality side effects 5/16/08 kdabueg none
adverse effects r/t bevacizumab 5/16/08 guest 1
Congress Session: Dermatologic Toxicities 5/8/08 jshinsky none
Monoclonal Antibody infusion 8/27/07 guest none


Powered by ReadyPortal from Red Dog Software Sitemap nbsp; |  Home

Copyright 2008 SIG. All rights reserved.